# Denison Pharmaceuticals, LLC, Lincoln, RI – FDA Inspections

Source: https://www.keypedia.com/companies/denison-pharmaceuticals-llc/c217e50a-bd7d-49c3-8f66-2bf20a1c71ec

> Inspection records and compliance data for Denison Pharmaceuticals, LLC in Lincoln, Rhode Island. 8 FDA inspections on record (2 OAI), 3 Form 483s, 1 warning letter, last inspected August 26, 2025.

---

## Details

- Name: Denison Pharmaceuticals, LLC
- FEI Number: 1210580
- Address Line 1: 1 Powder Hill Rd
- City: Lincoln
- State: Rhode Island
- Zip Code: 02865
- Country Name: United States
- Address: 1 Powder Hill Rd, Lincoln, Rhode Island 02865, United States
- Country: United States

## Related Documents

- [483 - Denison Pharmaceuticals, LLC - 2025-08-26](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/e815ef53-8947-42d3-bde7-29507582ed70) — source: FDA, date: August 26, 2025
- FDA Inspection 1273626 - Denison Pharmaceuticals, LLC - 2025-08-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2025
- [FDA Inspection 1273626 - Denison Pharmaceuticals, LLC - 2025-08-26](https://www.keypedia.com/records/fda_inspections/denison-pharmaceuticals-llc/49ae55a4-0103-41f8-8a75-60112f7dffd8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2025
- FDA Inspection 1273626 - Denison Pharmaceuticals, LLC - 2025-08-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2025
- [483 - Denison Pharmaceuticals, LLC - 2024-07-29](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/e4e9d792-bf44-4b54-b508-f0b77e37af5c) — source: FDA, date: July 29, 2024
- [FDA Inspection 1240591 - Denison Pharmaceuticals, LLC - 2024-07-29](https://www.keypedia.com/records/fda_inspections/denison-pharmaceuticals-llc/82db37bd-63b9-44ba-b418-fec608d1db49) — classification: Official Action Indicated (OAI), source: FDA, date: July 29, 2024
- [483 - Denison Pharmaceuticals, LLC - 2023-02-09](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/32644ea7-902e-47b5-b249-9fb1090948a8) — source: FDA, date: February 9, 2023
- [483 - Denison Pharmaceuticals, LLC - 2023-02-09](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/a5fe71a4-9389-46f4-9317-5e90e0d763eb) — source: FDA, date: February 9, 2023
- [WARNING_LETTER - Denison Pharmaceuticals, LLC - 2023-02-09](https://www.keypedia.com/records/warning_letter/denison-pharmaceuticals-llc/c2965870-94dc-43e6-b329-b059c7876903) — source: FDA, date: February 9, 2023
- [FDA Inspection 1196871 - Denison Pharmaceuticals, LLC - 2023-02-09](https://www.keypedia.com/records/fda_inspections/denison-pharmaceuticals-llc/0676d955-5878-4af8-9e48-26114410d8f5) — classification: Official Action Indicated (OAI), source: FDA, date: February 9, 2023
- [483 - Denison Pharmaceuticals, LLC - 2017-10-25](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/8581357a-2bb9-4dea-acbe-690a06c6bc36) — source: FDA, date: October 25, 2017
- [FDA Inspection 1029761 - Denison Pharmaceuticals, LLC - 2017-10-25](https://www.keypedia.com/records/fda_inspections/denison-pharmaceuticals-llc/f08c2fbb-4bbc-4b66-bb37-9eb81477694d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2017
- [483 - Denison Pharmaceuticals, LLC - 2016-04-05](https://www.keypedia.com/records/483/denison-pharmaceuticals-llc/6ef15e97-8d71-4470-b804-13e525c8ed0b) — source: FDA, date: April 5, 2016
- [FDA Inspection 969790 - Denison Pharmaceuticals, LLC - 2016-04-05](https://www.keypedia.com/records/fda_inspections/denison-pharmaceuticals-llc/9acb3892-b958-430e-8aee-0b7111de087c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2016
- FDA Inspection 969790 - Denison Pharmaceuticals, LLC - 2016-04-05 — classification: No Action Indicated (NAI), source: FDA, date: April 5, 2016
- FDA Inspection 969790 - Denison Pharmaceuticals, LLC - 2016-04-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2016
- FDA Inspection 969790 - Denison Pharmaceuticals, LLC - 2016-04-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2016

## Related Companies

- [Hospira, Inc., A Pfizer Company](https://www.keypedia.com/companies/hospira-inc-a-pfizer-company/46d63c80-caf7-40db-8325-13fcade5e82c)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Steril-Gene Life Sciences Private Ltd](https://www.keypedia.com/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec)
- [Haleon US Inc.](https://www.keypedia.com/companies/haleon-us-inc/59f65cda-88dc-4ec6-98a9-42bd852cb203)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Patheon Manufacturing Services LLC](https://www.keypedia.com/companies/patheon-manufacturing-services-llc/64087a9c-0f9c-44d7-aeb9-171f7bc13658)
- [CoreRX Inc.](https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Mission Pharmacal Company](https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6)
- [Pharmco Laboratories Inc.](https://www.keypedia.com/companies/pharmco-laboratories-inc/b34e3481-0ea5-433a-9e03-ce66b44df443)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)

## Related Officers

- [Nealie C. Newberger](https://www.keypedia.com/people/nealie-c-newberger/4b7addde-1217-4495-bac2-2f7e3fe2e780)
- [Program Division Director/District Director](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
- [Vascular Neurologist Investigator](https://www.keypedia.com/people/sean-d-duke/ea627ffa-8e7c-4c2e-a9e0-31a41fe44ccf)
- [Director](https://www.keypedia.com/people/joann-m/0a459cd4-7849-4687-8811-4868144e3be3)
